nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—Mood swings—Betamethasone—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Icosapent ethyl—Mood swings—Dexamethasone—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Icosapent ethyl—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Icosapent ethyl—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.0049	0.0049	CcSEcCtD
Icosapent ethyl—Increased appetite—Prednisone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Icosapent ethyl—Bronchitis—Triamcinolone—ankylosing spondylitis	0.00482	0.00482	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.00479	0.00479	CcSEcCtD
Icosapent ethyl—Neoplasm—Methotrexate—ankylosing spondylitis	0.00477	0.00477	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.00476	0.00476	CcSEcCtD
Icosapent ethyl—Affect lability—Prednisone—ankylosing spondylitis	0.00451	0.00451	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Methotrexate—ankylosing spondylitis	0.00449	0.00449	CcSEcCtD
Icosapent ethyl—Infestation—Methylprednisolone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Icosapent ethyl—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.0044	0.0044	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.00438	0.00438	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.00437	0.00437	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Icosapent ethyl—Mood swings—Prednisone—ankylosing spondylitis	0.00434	0.00434	CcSEcCtD
Icosapent ethyl—Sweating—Methylprednisolone—ankylosing spondylitis	0.00427	0.00427	CcSEcCtD
Icosapent ethyl—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00421	0.00421	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.00404	0.00404	CcSEcCtD
Icosapent ethyl—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00402	0.00402	CcSEcCtD
Icosapent ethyl—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.00399	0.00399	CcSEcCtD
Icosapent ethyl—Abdominal distension—Prednisone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Icosapent ethyl—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Icosapent ethyl—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Icosapent ethyl—Pancreatitis—Prednisone—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Icosapent ethyl—Mood swings—Methotrexate—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Icosapent ethyl—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Icosapent ethyl—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00352	0.00352	CcSEcCtD
Icosapent ethyl—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00348	0.00348	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00348	0.00348	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Icosapent ethyl—Malaise—Prednisolone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Icosapent ethyl—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Icosapent ethyl—Vertigo—Prednisolone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Icosapent ethyl—Syncope—Prednisolone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Icosapent ethyl—Back pain—Triamcinolone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Icosapent ethyl—Asthma—Methotrexate—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Icosapent ethyl—Hypertension—Prednisolone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Icosapent ethyl—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Icosapent ethyl—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Icosapent ethyl—Pancreatitis—Methotrexate—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Icosapent ethyl—Alopecia—Dexamethasone—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Icosapent ethyl—Alopecia—Betamethasone—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Icosapent ethyl—Discomfort—Prednisolone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Icosapent ethyl—Malaise—Triamcinolone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Icosapent ethyl—Malaise—Methylprednisolone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Icosapent ethyl—Vertigo—Triamcinolone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Icosapent ethyl—Syncope—Triamcinolone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Icosapent ethyl—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Icosapent ethyl—Syncope—Methylprednisolone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Icosapent ethyl—Oedema—Prednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Icosapent ethyl—Shock—Prednisolone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Icosapent ethyl—Cough—Triamcinolone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Icosapent ethyl—Tachycardia—Prednisolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Icosapent ethyl—Hypertension—Triamcinolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Icosapent ethyl—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Icosapent ethyl—Myalgia—Triamcinolone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Icosapent ethyl—Pneumonia—Methotrexate—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Icosapent ethyl—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Icosapent ethyl—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Icosapent ethyl—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Icosapent ethyl—Infestation—Methotrexate—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Icosapent ethyl—Discomfort—Triamcinolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Icosapent ethyl—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Icosapent ethyl—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Icosapent ethyl—Malaise—Dexamethasone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Icosapent ethyl—Malaise—Betamethasone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Icosapent ethyl—Oedema—Triamcinolone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Icosapent ethyl—Vertigo—Betamethasone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Icosapent ethyl—Vertigo—Dexamethasone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Icosapent ethyl—Syncope—Dexamethasone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Icosapent ethyl—Syncope—Betamethasone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Icosapent ethyl—Arrhythmia—Prednisone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Icosapent ethyl—Infection—Triamcinolone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Icosapent ethyl—Sweating—Methotrexate—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Icosapent ethyl—Infection—Methylprednisolone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Icosapent ethyl—Shock—Triamcinolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Icosapent ethyl—Insomnia—Prednisolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Icosapent ethyl—Alopecia—Prednisone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Icosapent ethyl—Shock—Methylprednisolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Icosapent ethyl—Epistaxis—Methotrexate—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Icosapent ethyl—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Icosapent ethyl—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Icosapent ethyl—Malnutrition—Prednisone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Icosapent ethyl—Hypertension—Betamethasone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Icosapent ethyl—Hypertension—Dexamethasone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Icosapent ethyl—Myalgia—Dexamethasone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Icosapent ethyl—Myalgia—Betamethasone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Icosapent ethyl—Discomfort—Dexamethasone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Icosapent ethyl—Discomfort—Betamethasone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Icosapent ethyl—Pain—Prednisolone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Icosapent ethyl—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Icosapent ethyl—Oedema—Dexamethasone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Icosapent ethyl—Oedema—Betamethasone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Icosapent ethyl—Insomnia—Triamcinolone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Icosapent ethyl—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Icosapent ethyl—Infection—Betamethasone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Icosapent ethyl—Infection—Dexamethasone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Icosapent ethyl—Shock—Betamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Icosapent ethyl—Shock—Dexamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Icosapent ethyl—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Icosapent ethyl—Tachycardia—Betamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Icosapent ethyl—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Icosapent ethyl—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Icosapent ethyl—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Icosapent ethyl—Malaise—Prednisone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Icosapent ethyl—Vertigo—Prednisone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Icosapent ethyl—Syncope—Prednisone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Icosapent ethyl—Anorexia—Betamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Icosapent ethyl—Anorexia—Dexamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Icosapent ethyl—Pain—Triamcinolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Icosapent ethyl—Hypertension—Prednisone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Icosapent ethyl—Chills—Methotrexate—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Icosapent ethyl—Myalgia—Prednisone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Icosapent ethyl—Arthralgia—Prednisone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Icosapent ethyl—Alopecia—Methotrexate—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Icosapent ethyl—Insomnia—Betamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Icosapent ethyl—Insomnia—Dexamethasone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Icosapent ethyl—Discomfort—Prednisone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Icosapent ethyl—Malnutrition—Methotrexate—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Icosapent ethyl—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Icosapent ethyl—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Icosapent ethyl—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Icosapent ethyl—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Icosapent ethyl—Oedema—Prednisone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Icosapent ethyl—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Icosapent ethyl—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Icosapent ethyl—Infection—Prednisone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Icosapent ethyl—Back pain—Methotrexate—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Icosapent ethyl—Shock—Prednisone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Icosapent ethyl—Pain—Dexamethasone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Icosapent ethyl—Pain—Betamethasone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Icosapent ethyl—Tachycardia—Prednisone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Icosapent ethyl—Anorexia—Prednisone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Icosapent ethyl—Malaise—Methotrexate—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Icosapent ethyl—Vertigo—Methotrexate—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Icosapent ethyl—Dizziness—Prednisolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Icosapent ethyl—Asthenia—Triamcinolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Icosapent ethyl—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Icosapent ethyl—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Icosapent ethyl—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Icosapent ethyl—Insomnia—Prednisone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Icosapent ethyl—Pruritus—Triamcinolone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Icosapent ethyl—Cough—Methotrexate—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Icosapent ethyl—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Icosapent ethyl—Dyspepsia—Prednisone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Icosapent ethyl—Arthralgia—Methotrexate—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Icosapent ethyl—Chest pain—Methotrexate—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Icosapent ethyl—Myalgia—Methotrexate—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Icosapent ethyl—Decreased appetite—Prednisone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Icosapent ethyl—Rash—Prednisolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Icosapent ethyl—Dermatitis—Prednisolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Icosapent ethyl—Discomfort—Methotrexate—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Icosapent ethyl—Constipation—Prednisone—ankylosing spondylitis	0.00192	0.00192	CcSEcCtD
Icosapent ethyl—Dizziness—Triamcinolone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Icosapent ethyl—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Icosapent ethyl—Infection—Methotrexate—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Icosapent ethyl—Asthenia—Betamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Icosapent ethyl—Asthenia—Dexamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Icosapent ethyl—Pruritus—Betamethasone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Icosapent ethyl—Pruritus—Dexamethasone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Icosapent ethyl—Vomiting—Triamcinolone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Icosapent ethyl—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Icosapent ethyl—Rash—Triamcinolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Icosapent ethyl—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Icosapent ethyl—Anorexia—Methotrexate—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Icosapent ethyl—Rash—Methylprednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Icosapent ethyl—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Icosapent ethyl—Body temperature increased—Prednisone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Icosapent ethyl—Dizziness—Dexamethasone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Icosapent ethyl—Dizziness—Betamethasone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Icosapent ethyl—Insomnia—Methotrexate—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Icosapent ethyl—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Icosapent ethyl—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Icosapent ethyl—Vomiting—Dexamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Icosapent ethyl—Vomiting—Betamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Icosapent ethyl—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Icosapent ethyl—Rash—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Icosapent ethyl—Rash—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Icosapent ethyl—Dermatitis—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Icosapent ethyl—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Icosapent ethyl—Asthenia—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Icosapent ethyl—Pain—Methotrexate—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Icosapent ethyl—Pruritus—Prednisone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Icosapent ethyl—Dizziness—Prednisone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Icosapent ethyl—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Icosapent ethyl—Vomiting—Prednisone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Icosapent ethyl—Rash—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Icosapent ethyl—Dermatitis—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Icosapent ethyl—Asthenia—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Icosapent ethyl—Pruritus—Methotrexate—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Icosapent ethyl—Dizziness—Methotrexate—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Icosapent ethyl—Vomiting—Methotrexate—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Icosapent ethyl—Rash—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Icosapent ethyl—Dermatitis—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
